Nuvasive Inc
NUVADelisted Sep 1, 2023- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001142596
Nuvasive Inc was delisted on Sep 1, 2023; its insiders filed their last Form 4 on Sep 5, 2023; 229 institutions reported holding it in 13F filings for Q2 2023, worth $2.39B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nuvasive Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nuvasive Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Friel Robert F | Director | – | Sep 5, 2023 | 0 |
| Sisitsky Nathaniel | SVP & General Counsel | 0 | Sep 5, 2023 | 0 |
| Capps Vickie L | Director | 0 | Sep 5, 2023 | 0 |
| Huennekens R Scott | Director | 0 | Sep 5, 2023 | 0 |
| DeFord John A | Director | – | Sep 5, 2023 | 0 |
| Norwalk Leslie V | Director | 0 | Sep 5, 2023 | 0 |
| Kadia Siddhartha | Director | 0 | Sep 5, 2023 | 0 |
| Harbaugh Matthew K | EVP and CFO | 0 | Sep 5, 2023 | 0 |
| Wolterman Dan | Director | – | Sep 5, 2023 | 0 |
| Barry James Christopher | Chief Executive Officer | 0 | Sep 5, 2023 | 0 |
| Wolf Dale A. | SVP, Global Operations | 0 | Sep 5, 2023 | 0 |
| Raimundo Amy Belt | Director | – | Sep 5, 2023 | 0 |
| Farrington Michael | SVP, People and Culture | 0 | Sep 5, 2023 | 0 |
| Rosenbaum Marc W. | Chief Accounting Officer | 11,579 | Mar 3, 2023 | 0 |
| Rosenberg Donald J | Director | 22,519Indirect | May 13, 2022 | 0 |
| Morton Andrew C. | SVP, CHRO | – | Mar 3, 2022 | 0 |
| Calafiore Massimo | EVP, Chief Commercial Officer | 7,207 | Mar 3, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2022 (view filing) | Mar 28 | 2 days | Barry James ChristopherChief Executive Officer | SSale | −5.00K | $55.00 | −$275.0K | −8.3%55.2K after | |
| Apr 15, 2022 (view filing) | Apr 13 | 2 days | Barry James ChristopherChief Executive Officer | SSale | −5.00K | $58.00 | −$290.0K | −9.1%50.2K after |